Together these results suggest that the ALS mutations in ubiquilin-2 that we studied impede protein degradation by capturing, but failing to deliver the captured ubiquitinated cargo to the proteasome. This evidence concerns the gene UBQLN2 and amyotrophic lateral sclerosis.